ALN-RSV01

DRUG3 trials

Sponsors

Alnylam Pharmaceuticals

Conditions

Respiratory Syncytial Virus Infections

Phase 2

Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus

CompletedNCT00496821

Alnylam PharmaceuticalsRespiratory Syncytial Virus Infections

Start: 2007-07-31End: 2007-11-30Target: 88Updated: 2007-11-30

Phase 2 Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

CompletedNCT00658086

Alnylam PharmaceuticalsRespiratory Syncytial Virus Infections

Start: 2008-04-30End: 2009-06-30Updated: 2018-01-29

Phase 2b Study of ALN-RSV01 in Lung Transplant Patients Infected With Respiratory Syncytial Virus (RSV)

CompletedNCT01065935

Alnylam PharmaceuticalsRespiratory Syncytial Virus Infections

Start: 2010-02-28End: 2012-05-31Updated: 2018-02-05